Notably, CD36-mediated uptake of oxidized LDL (ox-LDL) triggers a pathway involving Nogo-B and CEBPβ expression, ultimately reprogramming ox-LDL metabolism and driving cancer development in NAFLD-associated HCC [63]. This evidence concerns the gene CD36 and hepatocellular carcinoma.